Asia-Pacific Knee Cartilage Repair Market, By Product (Cell-Based & Non-Cell Based), Modality (Osteochondral Transplantation, Microfracture, Abrasion Arthroplasty, Drilling, Chondrocyte Implantation, and Others), Cartilage Type (Hyaline Cartilage, and Fibrocartilage), Application (Osteoarthritis, Rheumatoid Arthritis, Steonecrosis, Fractures, Bone Tumors, and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes, and Others), Distribution Channel (Direct Sales, Third Party Distributor, Online Sales, and Others), Industry Trends and Forecast to 2030.
Asia-Pacific Knee Cartilage Repair Market Analysis and Insights
The product launches are expected to pave the growth of the industries to increase the sales and distribution of knee cartilage repair for knee disorders. The product launch will generate new partnerships and business collaborations. The launch would allow the customers to purchase the new product available to them. The launches are likely to depict a positive trend in market growth.
Moreover, the rise in the incidence of knee diseases, the rise in the geriatric population, the rise in awareness about knee treatment in Asia-Pacific, and the technological developments in knee cartilage repair devices are expected to drive market growth. The strategic initiatives taken by key market players are also boosting market growth in the forecasted period.
However, the high cost of knee surgeries and the problems faced while using knee orthopedics are expected to restrain the market growth.
Data Bridge Market Research analyses that the Asia-Pacific knee cartilage repair market will grow at a CAGR of 11.1% during the forecast period of 2023 to 2030.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2020-2016) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product (Cell-Based & Non-Cell Based), Modality (Osteochondral Transplantation, Microfracture, Abrasion Arthroplasty, Drilling, Chondrocyte Implantation, and Others), Cartilage Type (Hyaline Cartilage, and Fibrocartilage), Application (Osteoarthritis, Rheumatoid Arthritis, Steonecrosis, Fractures, Bone Tumors, and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes, and Others), Distribution Channel (Direct Sales, Third Party Distributor, Online Sales, and Others). |
|
Countries Covered |
Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific. |
|
Market Players Covered |
Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others |
Market Definition:
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Cartilage is the most common type of connective tissue. It is found in various forms throughout our joints, spine, bones, ears, lungs, and nose. Cartilage is a flexible connective tissue that coats the surfaces of the bones in our joints and protects them against impact to maintain joint mobility fluid.
Knee cartilage repair is a procedure that involves repairing damaged cartilage while also smoothing the tissue's remaining surface. Cartilage repair surgery, which attempts to restore cartilage tissue and function to avoid long-term osteoarthritis, is an appropriate treatment choice for focal full-thickness cartilage abnormalities in the knee. Osteotomy, knee replacement, and microfracture are some of the most common knee cartilage repair techniques. The surgical techniques or less prevalent surgical procedures, such as allograft osteochondral transplantation, autologous chondrocyte implantation, and artificial scaffolds, are sometimes utilized to repair cartilage injury.
Asia-Pacific Knee Cartilage Repair Market Dynamics
Drivers
-
INCREASE IN THE PREVALENCE OF KNEE DISORDERS
The most common joint disorder among the elderly is knee osteoarthritis (OA), where the destruction and loss of articular cartilage is a central feature in most forms of arthritis, including the most common form that is osteoarthritis. With osteoarthritis, the cartilage within a joint begins to break down, and the underlying bone changes. It not only causes patients pain and physical impairment but also imposes a significant disease burden on the population as a whole. Years Lived with Disability (YLD) is the standard metric to quantify disease burden in most chronic diseases, such as osteoarthritis. One year of disability is equivalent to one year of "healthy" life lost. The sum of YLDs across the population, the disease burden, represents the difference between current health status and an ideal health situation in which the entire population lives to an advanced age free of disease and disability. The rise in the incidence of chronic knee disorders is expected to boost the sales and supply of medication and implants for the treatment of knees in Asia-Pacific. It is expected to meet the patient's requirements. The knowledge about the prevalence and incidence of orthopedic knee diseases would help find novel solutions and aid in more collaborations and partnerships with market players based in countries in the Asia-Pacific region. Hence, the rise in knee disorders is expected to boost market growth.
-
RISE IN THE NUMBER OF KNEE SURGERIES
Hip and knee replacements and surgeries are some of the most frequently performed and effective surgeries in Asia-Pacific. Osteoarthritis is the main indication for hip and knee replacement and surgery as osteoarthritis is also the reason for cartilage damage and destruction of the articular cartilage, so the surgeries due to osteoarthritis also involve cartilage repair. Knee surgeries are becoming quite common in Asia-Pacific due to the growing prevalence of sports-related knee injuries and expanding indications for total knee replacement due to patient and surgeon preferences.
The rise in knee surgeries in Asia-Pacific countries would ensure timely awareness and treatment of patients with chronic knee morbidities. Technological development would be of crucial importance in the development of advanced knee implants. Further optimization and novel technological developments would open the use of 3D implants. The rise in the number of knee surgeries is expected to drive the Asia-Pacific knee cartilage repair market growth.
Opportunities
-
RISE IN AWARENESS ABOUT KNEE TREATMENT
Understanding knee disorders and the scope of the treatment is vital to help and guiding people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Awareness about the symptoms and treatment of chronic knee diseases by public and private institutes would result in timely treatment and provide access to inexpensive universal health aid along with increased availability of rehabilitative treatment. The Asia-Pacific Knee Society (APKS) was created to bring the key opinion leaders in the field of Asia-Pacific's degenerative knee and knee arthroplasty together and gather valuable information about growing trends and awareness.
The awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions to supply and distribute the devices. This will result in a rise in product and business line expansion. Hence, a rise in awareness among people about timely treatment is expected to act as an opportunity for market growth.
-
GROWING GERIATRIC POPULATION
Knee disorders, namely knee osteoarthritis, and ligament tears, are common in the elderly population in Asia-Pacific. Bone problems are likely to affect persons 60 years and older, especially those residing in long-term care institutions. As the elderly population ages, the prevalence of knee diseases may rise, opening the door for the development of drugs and implants in diagnostic and preventive methods vital for improving knee disorders in older persons. Along with other risk factors, the vulnerability to knee diseases also increases with age. Osteoarthritis of the knee can be brought on by injury, infection, or being overweight, or it might be inherited in certain people. Women are more likely to experience the same.
A type of connective tissue called cartilage can be found throughout the body. Despite being a strong and flexible material, it is relatively simple to harm. Additionally, the cartilage gradually deteriorates with age, and osteoarthritis sufferers frequently experience stiffness, especially after prolonged periods of sitting or lying down. The joints' capacity to withstand demands decreases as the body's natural shock absorbers deteriorate. With advancing age, bone density and muscle tone gradually deteriorate, making physically demanding occupations even more challenging. Therefore, the expanding elderly population experiences more bone and joint problems that require early treatment and are therefore anticipated to propel market expansion.
As the geriatric population increases and suffering from chronic knee increases, it would result in increased treatment demand. Therefore, the rise in the geriatric population is expected to boost the growth of the market.
Restraints/Challenges
- HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES
Knee arthroplasty is a popular procedure but exhibits a high cost. The cost of knee implants is due to technological development and the rising preference for less invasive orthopedic knee implants.
The cost of Autologous Chondrocyte Implantation (ACI) is expensive. Osteochondral allograft transplantation is a specialized procedure. Its cost is thus high depending upon the cost of the allografts. It ranges from around $10,000. Hence, it is expected to hamper the market growth.
Post-COVID-19 Impact on Asia-Pacific Knee Cartilage Repair Market
COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration has impacted the market.
Recent Development
- In March 2022, CritiCare Asia launched Cuvis 3rd Generation Robotic Arm Technology for joint replacement surgeries to enable surgeons to perform complex joint replacement surgeries precisely by overcoming the challenges they face during traditional open surgeries. This way, artificial intelligence aid the surgeries with minimally invasive.
Asia-Pacific Knee Cartilage Repair Market Scope
The Asia-Pacific knee cartilage repair market is categorized into six segments based on product, modality, cartilage type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Cell-Based
- Non-Cell-Based
Based on product, the Asia-Pacific knee cartilage repair market is segmented into cell-based and non-cell-based.
Modality
- Osteochondral Transplantation
- Microfracture
- Abrasion Arthroplasty
- Drilling
- Chondrocyte Implantation
- Others
Based on modality, the Asia-Pacific knee cartilage repair market is segmented into chondrocyte implantation, microfracture, drilling, abrasion arthroplasty, osteochondral transplantation, and others.
Cartilage Type
- Hyaline Cartilage
- Fibrocartilage
Based on cartilage type, the Asia-Pacific knee cartilage repair market is segmented into hyaline cartilage and fibrocartilage.
Application
- Osteoarthritis
- Rheumatoid Arthritis
- Bone Tumors
- Fractures
- Steonecrosis
Based on application, the Asia-Pacific knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, bone tumors, fractures, and steonecrosis.
End User
- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics
- Research And Academic Institutes
- Others
Based on end user, the Asia-Pacific knee cartilage repair market is segmented into hospital, ambulatory surgical centers, specialty clinics, research and academic institutes, and others.
Distribution Channel
- Direct Sales
- Third Party Distributor
- Online Sales
- Others
Based on distribution channel, Asia-Pacific knee cartilage repair market is segmented into direct sales, third party distributor, online sales, and others.
Asia-Pacific Knee Cartilage Repair Regional Analysis/Insights
The Asia-Pacific knee cartilage repair market is analyzed, and market size insights and trends are provided by country, product, modality, cartilage type, application, end user, and distribution channel, as referenced above.
The Asia-Pacific knee cartilage repair market is expected to grow due to an increase in cases of knee disorders and the growing geriatric population. The increasing risk of fractures related to osteoporosis and accident cases is also driving the market growth. In addition, rising initiatives by market players to launch advanced products in the region will further boost market growth in the forecast period.
China is expected to dominate the Asia-Pacific knee cartilage repair market due to advanced technology, the high prevalence of knee osteoarthritis, and an established healthcare system.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of other brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Knee Cartilage Repair Market Share Analysis
The Asia-Pacific knee cartilage repair market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the Asia-Pacific knee cartilage repair market.
Some of the major players operating in the Asia-Pacific knee cartilage repair market are Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others.
SKU-
